Two drug strategies boost myelin repair in MS models, cutting neuroinflammation

MedicalXpress | mai 04, 2026

Multiple sclerosis (MS) is most prevalent in Northern Europe and Canada, and more common in the northernmost latitudes. In recent years, the number of cases has grown, particularly among women. The disease causes the patient's own immune system to attack a protective coating known as myelin that surrounds nerve cells. When this sheath is destroyed, neuronal function decreases and the cells can ultimately die. This can result in visual disturbances, fatigue, mobility difficulties, and other neurological symptoms that may be permanent.